Why We Built Thalocan: The Forgotten Links in Dermatology Clinical Trials
Why We Built Thalocan: The Forgotten Links in Dermatology Clinical Trials Interview with Eric Zudak, CEO of Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. There’s a moment in every startup story when frustration turns into fuel. For Eric Zudak, founder of Thalocan Research Innovations, that moment came when a global pharmaceutical company called…